Professor of Preventive Medicine/ Medicine /Physiology at University of Tennessee Health Science Center

Internal Medicine

Dr. William C. Cushman, MD

Dr. William C. Cushman works in the field of Internal Medicine. He graduated from University of Mississippi School of Medicine. He has 1 awards "America's Top Doctors". Dr. William C. Cushman is a published doctor. He published 47 publications, including: 'SPRINT Trial Results: Latest News in Hypertension Management.'

Publications

SPRINT Trial Results: Latest News in Hypertension Management.
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease: Results From the Antihypertensive and Lipid-Lowering Treatmen...
Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from th...
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial.
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Tria...
Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).
Chlorthalidone Versus Hydrochlorothiazide in Hypertension Treatment: Do We Have the Evidence to Decide?
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes.
Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Results by Sex.
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
Module 2: Rethinking the role of thiazide-type diuretics in the management of hypertension: which diuretic is best?
Home and clinic blood pressure responses in elderly individuals with systolic hypertension.
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results.
EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) A cardio...
New recommendations for treating hypertension in black patients: evidence and/or consensus?
Disparity implications of Medicare eligibility criteria for medication therapy management services.
Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death.
Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results...
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
National utilization of antihypertensive medications from 2000 to 2006 in the Veterans Health Administration: focus on thiazide diuretics.
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Counci...
The treatment of hypertension in the elderly.
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
Control of blood pressure: does it matter which agent you use?
JNC-7 guidelines: are they still relevant?
What should our blood pressure goal be in patients with diabetes?
Achieving blood pressure goals: why aren't we?
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.
Hypertension in adults across age groups.
Hypertension and heart failure. Roundtable discussion.
Are there benefits to specific antihypertensive drug therapy?
The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression.
Hypertension control in clinical practice with a new standard in angiotensin II receptor blockade.
The effect of a losartan-based treatment regimen on isolated systolic hypertension.
Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Hypertension in Older Persons.
Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.

Schools

Univ Of Ms Sch Of Med
University Miss Med Center

Doctors Specialties

Internal Medicine

Accepted Insurances

Awards

America's Top Doctors

Education

University of Mississippi Medical Center
University of Mississippi School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Brenda M. Hardy, MD This Doctor is OpenDoctor Recommended.
	Dr. Marcia D. Bradford, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph A. Mixon, MD This Doctor is OpenDoctor Recommended.
	Dr. Mohamad K. Moughrabieh, MD
	Dr. Kenneth S. Robinson, MD
	Dr. Syed N. Haider, MD